Shane Maltbie - Hillevax CFO Treasurer

HLVX Stock  USD 1.93  0.01  0.52%   

CFO

Shane Maltbie is CFO Treasurer of Hillevax
Age 42
Address 321 Harrison Avenue, Boston, MA, United States, 02118
Phone617 213 5054
Webhttps://www.hillevax.com

Latest Insider Transactions

2024-02-08Disposed of 3576 shares @ 14.93View

Hillevax Management Efficiency

The company has return on total asset (ROA) of (0.289) % which means that it has lost $0.289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6224) %, meaning that it created substantial loss on money invested by shareholders. Hillevax's management efficiency ratios could be used to measure how well Hillevax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2024. Return On Capital Employed is likely to rise to -0.4 in 2024. At this time, Hillevax's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 2 M in 2024, whereas Total Assets are likely to drop slightly above 173.7 M in 2024.
Hillevax currently holds 51.19 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Hillevax has a current ratio of 34.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hillevax's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

CFO Age

David JDPharvaris BV
70
Edward AlbiniSutro Biopharma
66
Daniel MBAOpthea
67
Edward MBASutro Biopharma
66
John CPACentessa Pharmaceuticals PLC
50
MD MBACentessa Pharmaceuticals PLC
53
Adam LevyMineralys Therapeutics, Common
46
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. Hillevax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people. Hillevax (HLVX) is traded on NASDAQ Exchange in USA. It is located in 321 Harrison Avenue, Boston, MA, United States, 02118 and employs 90 people. Hillevax is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Hillevax Leadership Team

Elected by the shareholders, the Hillevax's board of directors comprises two types of representatives: Hillevax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hillevax. The board's role is to monitor Hillevax's management team and ensure that shareholders' interests are well served. Hillevax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hillevax's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anju Chatterji, VP Operations
Kaia Agarwal, VP Affairs
Astrid MD, Chief Officer
Shane Maltbie, CFO Treasurer
Sean McLoughlin, Chief Officer
Paul JD, Secretary Counsel
Ozzie Berger, Senior Affairs
David Socks, Chief Officer
Aditya Kohli, Chief CoFounder

Hillevax Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hillevax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hillevax Stock Analysis

When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.